Settlement Gives Celltrion Date For US Higher-Strength Humira Biosimilar

Plans Q3 2023 Launch For Yuflyma 100mg/ml Citrate-Free Version Of Adalimumab

 
• By David Wallace
  
Queue line of wooden people waiting
Celltrion has joined a number of other Humira biosimilar sponsors waiting for launch in 2023 • Source: Roman Samborskyi / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin